muscle fixative solution (Servicebio Inc)

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Servicebio Inc muscle fixative solution
Muscle Fixative Solution, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fixative+solution/fixative+solution/pmc13196038-124-17-22
Average 86 stars, based on 1 article reviews

muscle fixative solution - by Bioz Stars, 2026-10

86/100 stars

Images

Transmission Assay:

Article Title: Repurposing dronedarone induces ferroptosis through GPX4 inactivation and degradation in pancreatic cancer.
Article Snippet: .. Transmission electron microscopy (TEM) Following dronedarone treatment, pancreatic cancer cells were fixed with EM fixative solution (Servicebio, China) at 4°C overnight. ..

Electron Microscopy:

Transmission Electron Microscopy:

Sequencing:

Article Title: Dopamine enhances surface glial glycolysis via acetylcholine and insulin/insulin-like growth factor signaling in the honeybee
Article Snippet: .. Brains were dissected and placed into centrifuge tubes containing fixative solution (Servicebio, Catalog No. G1113) for 24 h. The tissues then underwent dehydration and clearing through the following sequence: 4 h in 75% ethanol, 2 h in 85% ethanol, 2 h in 90% ethanol, 1 h in 95% ethanol, 30 min in absolute ethanol I, 30 min in absolute ethanol II, 5 min in alcohol–benzene, 10 min in xylene I, and 10 min in xylene II. ..

Staining:

Article Title: From Pathway Tracing to Actionable Targets: Integrative Mendelian Randomization and Experimental Triangulation Map Metabolic Pathways Across Ovarian Cancer Histotypes.
Article Snippet: .. At the endpoint, the medium was discarded, cells were gently washed with PBS, fixed with fixative solution (Servicebio, G1101, Wuhan, China) for 15–30 min, and stained with crystal violet solution (Servicebio, G1014, Wuhan, China) for 10–20 min. ..

other:

Article Title: Developmental transition of brown adipose tissue from a thermogenic to a lipogenic phenotype in neonatal goats revealed by single-nucleus transcriptomics.
Article Snippet: One portion of each PRAT sample was fixed in fixative solution (Servicebio, China), and another portion was immediately frozen in liquid nitrogen and stored at −80°C.

Blocking Assay:

Article Title: EXPRESS: Olfactory ensheathing cell transplantation targets macrophage extracellular traps and NKCC1 to alleviate pain after spinal cord injury.
Article Snippet: Finally, sections were mounted onto gelatin-coated slides using an anti-fluorescence quenching mounting medium with DAPI (Beyotime, China), dried, and imaged under an upright fluorescence microscope. .. RAW 264.7 cells or OECs were fixed with 4% fixative solution (Servicebio, China) for 15 min and permeabilized with 0.1% Triton X-100 (Beyotime, China) for 10 min. After blocking with 5% BSA (solarbio, China) in PBS for 30 min at 37°C, samples were incubated overnight at 4°C with primary antibodies against NKCC1 (ab303518, 1:1000; Abcam, UK), CD68 (ab283654, 1:1000; Abcam, UK), H3Cit (68345-1-Ig, 1:5000; Proteintech, China), or p75^NTR (ab52987, 1:50, Abcam, UK). .. Cells were washed 3 times in PBS (1 min each) and then incubated for 30 min at 37 °C in the dark with either CoraLite594-conjugated goat anti-mouse IgG (SA00013-3, 1:250; Proteintech, China) or CoraLite488-conjugated goat anti-rabbit IgG antibodies (SA00013-2, 1:500; Proteintech, China).

Incubation:

Article Title: In vivo genetic circuit drives systemic PARP1 siRNA assembly into small extracellular vesicles for BRCA2-deficient breast cancer therapy.
Article Snippet: Rationale: BRCA2-mutant breast cancer is a major clinical challenge, with current poly ADPribose polymerase inhibitor (PARPi) therapies limited by systemic toxicity and acquired resistance.. This study aimed to develop a RNA interference (RNAi) strategy to selectively inhibit PARP1 in breast tumors via a systemic, non-viral delivery platform.. Methods: We designed a genetic circuit as a naked DNA plasmid, encoding a PARP1-specific siRNA embedded within a pre-miR-155 backbone under the control of a cytomegalovirus (CMV) promoter.

Review